Cannabis
River Oaks Treatment Center Warns of the Dangers of Delta-8-Tetrahydrocannabinol
<!– Name:DistributionId Value:8839746 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:4533 –> <!– Name:CustomerId Value:500106048 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:8a1fe020-305e-4807-af32-8fbbd41cfe24 –>
RIVERVIEW, Fla., May 16, 2023 (GLOBE NEWSWIRE) — Delta-8-Tetrahydrocannabinol (Delta-8 THC) is a widely sold product, but River Oaks Treatment Center, a leading provider of treatment for substance use and co-occurring mental health conditions, has issued a warning to consumers about the potential dangers associated with its consumption.
“My main concern is that people buying these products are under the impression that it’s pure and natural when that certainly is not the case,” said Jeff Turiczek, CEO of River Oaks Treatment Center. “What they’re really consuming is a diluted substance that’s manufactured with no oversight resulting in a drug containing questionable, and potentially lethal, additives that they’re not aware of.”
Delta-8 THC is a naturally occurring cannabinoid, but it exists in small amounts that are not nearly enough for the mass manufacturing of products that contain the substance. Instead, cannabidiol oil, or CBD oil, is exposed to a number of chemicals and processes resulting in a reaction that produces Delta-8 THC. The active ingredient in just about every Delta-8 THC product sold to consumers – including tinctures and gummies – was produced in this manner.
What consumers are not aware of is the presence of residual metals, acids, unidentified compounds and other chemical reaction byproducts in Delta-8 THC products. Other additives, such as K2 or Spice, and cannabinoids not found in nature are also ingredients that have been found in these products,
“Patients that we see who have a history of using Delta-8 THC have many of the same adverse psychiatric effects exhibited by individuals with a history of synthetic cannabis use,” said Turiczek. “We see a lot of aggression, worsened psychiatric conditions, suicidal ideation, psychosis and a host of other physiological symptoms associated with this substance’s use, and it seems as though users are unaware of these potential outcomes.”
Unfortunately, experts at River Oaks Treatment Center believe the use of Delta-8 THC products can possibly get worse.
“A couple months back, there was a story out of Pennsylvania in which the district attorney asserted fentanyl and heroin were found in packaged Delta-8 products and my first thought was that it’s not that far-fetched,” said Turiczek. “Iso, nitazene analogs, xylazine, para-fluorofentanyl and many other substances are currently in the illicit drug supply throughout FL; with no oversight, who’s to say these adulterants can’t make it into Delta-8 products?”
About River Oaks Treatment Center
River Oaks Treatment Center is located near Tampa, FL. River Oaks treats patients who are struggling with drug addiction, alcohol addiction and co-occurring mental/behavioral health issues. For more information, call 813-213-4987.
River Oaks Treatment Center
12012 Boyette Road
Riverview, FL 33569
813-213-4987
Contact:
Maz Rodriguez
Public Relations Manager
[email protected]
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan5 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf5 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care